Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran
- PMID: 18703368
- DOI: 10.1016/j.ijid.2008.04.014
Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran
Abstract
Background: The empirical therapy of urinary tract infections (UTI) relies on the predictability of the agents causing UTI and knowledge of their antimicrobial susceptibility patterns.
Methods: In a prospective study undertaken over a 14-month period, 5136 samples from patients suspected of having a UTI were analyzed, of which 676 were culture-positive. Isolated bacteria were identified by standard tests, and antibiotic susceptibility was determined by disk diffusion method.
Results: According to our results, Escherichia coli was the most common etiological agent of UTI (74.6%), followed by Klebsiella spp (11.7%), Staphylococcus saprophyticus (6.4%), and Pseudomonas aeruginosa (2.2%). Analysis of the frequency of isolated bacteria according to the age of the patients revealed that Klebsiella infections are more prevalent in the older age groups (>10 years) and Pseudomonas infections are more prevalent in children and the elderly (<9 years and >60 years). Results of antimicrobial susceptibility analysis for E. coli, as the most prevalent cause of UTI, to commonly used antibiotics are as follows: amikacin (97.8%), gentamicin (97%), ciprofloxacin (94%), nitrofurantoin (87.1%), nalidixic acid (93.7%), trimethoprim-sulfamethoxazole (48.2%), cephalexin (76%), and ampicillin (6.9%).
Conclusions: The results show that the antimicrobial resistance patterns of the causes of UTI are highly variable and continuous surveillance of trends in resistance patterns of uropathogens is important.
Similar articles
-
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.Int J Antimicrob Agents. 2006 Nov;28(5):413-6. doi: 10.1016/j.ijantimicag.2006.08.009. Epub 2006 Sep 26. Int J Antimicrob Agents. 2006. PMID: 17000085
-
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.J Antimicrob Chemother. 2007 Feb;59(2):309-12. doi: 10.1093/jac/dkl466. Epub 2006 Nov 29. J Antimicrob Chemother. 2007. PMID: 17138569
-
[Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].Rev Med Chil. 2001 Aug;129(8):877-85. Rev Med Chil. 2001. PMID: 11680961 Spanish.
-
The etiology of urinary tract infection: traditional and emerging pathogens.Dis Mon. 2003 Feb;49(2):71-82. doi: 10.1067/mda.2003.8. Dis Mon. 2003. PMID: 12601338 Review.
-
Management of complicated urinary tract infections in the era of antimicrobial resistance.Postgrad Med. 2010 Nov;122(6):7-15. doi: 10.3810/pgm.2010.11.2217. Postgrad Med. 2010. PMID: 21084776 Review.
Cited by
-
Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya.Libyan J Med. 2015 Feb 2;10(1):26412. doi: 10.3402/ljm.v10.26412. eCollection 2015. Libyan J Med. 2015. PMID: 25651907 Free PMC article.
-
Prevalence of Cefepime-Resistant Escherichia coli in Iran: A Meta-Analysis (2007-2016).Iran J Public Health. 2019 Apr;48(4):603-611. Iran J Public Health. 2019. PMID: 31110970 Free PMC article. Review.
-
A retrospective study of the changing trends of antimicrobial resistance of Klebsiella pneumoniae isolated from urine samples over last 3 years (2012-2014).J Nat Sci Biol Med. 2016 Jan-Jun;7(1):39-42. doi: 10.4103/0976-9668.175060. J Nat Sci Biol Med. 2016. PMID: 27003967 Free PMC article.
-
Prevalence and Resistance Patterns of Pediatric Urinary Tract Infections in Bahrain.Cureus. 2021 Dec 31;13(12):e20859. doi: 10.7759/cureus.20859. eCollection 2021 Dec. Cureus. 2021. PMID: 35141098 Free PMC article.
-
Antibacterial activity of Syzygium aromaticum (clove) against uropathogens producing ESBL, MBL, and AmpC beta-lactamase: Are we close to getting a new antibacterial agent?J Family Med Prim Care. 2020 Jan 28;9(1):180-186. doi: 10.4103/jfmpc.jfmpc_908_19. eCollection 2020 Jan. J Family Med Prim Care. 2020. PMID: 32110587 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous